Format

Send to:

Choose Destination
See comment in PubMed Commons below
Trends Biotechnol. 1997 Feb;15(2):71-6.

Hepatitis C virus diagnostics: technology, clinical applications and impacts.

Author information

  • 1Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD 20892, USA. cathyc@cc.nih.gov

Abstract

Infection with hepatitis C virus (HCV) can cause several significant health problems. Sensitive and specific assays for antibodies to HCV are available to identify and confirm individuals infected with HCV. Evaluation of the clinical impact of HCV infection in a patient includes measuring liver biochemistries and possibly liver biopsy. Molecular assays such as HCV genotype identification and qualitative/quantitative HCV RNA analyses may be valuable in considerations of prognosis and therapy. Further refinement of antibody screening and confirmatory assays and standardization of molecular testing are necessary to optimize testing and thus fully characterize the diagnosis of HCV infection.

PMID:
9081301
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk